The main purpose of this study is to discover a new treatment for patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD). This study will focus on ADPKD with respects to the changes in the Total Kidney Volume (TKV). The TKV will be monitored and assessed with MRI, throughout the course of the study, as this study will involve treatment with a Investigational Medicinal Product (IMP).
The PI of this project was: Gauri Bhutani, MD
This project was funded by: Dept. of Medicine Nephrology, Industry-sponsored
The term of this project was: June 2019 to January 2022
The number of subjects scanned during this project was: 10